prikaz prve stranice dokumenta The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease
  Preuzmi
PDF 5.08 MB
Znanstveni rad - Izvorni znanstveni rad
The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease
Progress in Neurobiology, 168 (2018); 104-127. https://doi.org/10.1016/j.pneurobio.2018.05.001
Jazvinšćak Jembrek, Maja; Slade, Neda; Hof, Patrick R.; Šimić, Goran

Citirajte ovaj rad

Jazvinšćak Jembrek, M., Slade, N., Hof, P. R. i Šimić, G. (2018). The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease. Progress in Neurobiology, 168., 104-127. doi: 10.1016/j.pneurobio.2018.05.001

Jazvinšćak Jembrek, Maja, et al. "The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease." Progress in Neurobiology, vol. 168, 2018, str. 104-127. https://doi.org/10.1016/j.pneurobio.2018.05.001

Jazvinšćak Jembrek, Maja, Neda Slade, Patrick R. Hof i Goran Šimić. "The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease." Progress in Neurobiology 168 (2018): 104-127. https://doi.org/10.1016/j.pneurobio.2018.05.001

Jazvinšćak Jembrek, M., et al. (2018) 'The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease', Progress in Neurobiology, 168, str. 104-127. doi: 10.1016/j.pneurobio.2018.05.001

Jazvinšćak Jembrek M, Slade N, Hof PR, Šimić G. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease. Progress in Neurobiology [Internet]. 09.2018. [pristupljeno 02.05.2024.];168:104-127. doi: 10.1016/j.pneurobio.2018.05.001

M. Jazvinšćak Jembrek, N. Slade, P. R. Hof i G. Šimić, "The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease", Progress in Neurobiology, vol. 168, str. 104-127, Rujan 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:226379. [Citirano: 02.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:226379
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease
AutorMaja Jazvinšćak Jembrek
AutorNeda Slade
AutorPatrick R. Hof
AutorGoran Šimić
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Sažetak (engleski)
Alzheimer's disease (AD), the most common progressive neurodegenerative disorder, is characterized by severe cognitive decline and personality changes as a result of synaptic and neuronal loss. The defining clinicopathological hallmarks of the disease are deposits of amyloid precursor protein (APP)-derived amyloid-β peptides (Aβ) in the brain parenchyma, and intracellular aggregates of truncated and hyperphosphorylated tau protein in neurofibrillary tangles (NFT). At the cellular and molecular levels, many intertwined pathological mechanisms that relate Aβ and tau pathology with a transcription factor p53 have been revealed. p53 is activated in response to various stressors that threaten genomic stability. Depending on damage severity, it promotes neuronal death or survival, predominantly via transcription-dependent mechanisms that affect expression of apoptosis-related target genes. Levels of p53 are enhanced in the AD brain and maintain sustained tau hyperphosphorylation, whereas intracellular Aβ directly contributes to p53 pool and promotes downstream p53 effects. The review summarizes the role of p53 in neuronal function, discusses the interactions of p53, tau, and Aβ in the normal brain and during the progression of AD pathology, and considers the impact of the most prominent hereditary risk factors of AD on p53/tau/Aβ interactions. A better understanding of this intricate interplay would provide deeper insight into AD pathology and might offer some novel therapeutic targets for the improvement of treatment options. In this regard, drugs and natural compounds targeting the p53 pathway are of growing interest in neuroprotection as they may represent promising therapeutic approaches in the prevention of oxidative stress-dependent pathological processes underlying AD.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaProgress in Neurobiology
Brojčani podacivol. 168, str. 104-127
p-ISSN0301-0082
DOIhttps://doi.org/10.1016/j.pneurobio.2018.05.001
URN:NBNurn:nbn:hr:105:226379
Datum objave publikacije2018-09
URL dokumentahttp://doi.org/10.1016/j.pneurobio.2018.05.001
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 10:20:13